Knight Therapeutics (FRA:04K) Float Percentage Of Total Shares Outstanding: 0.00% (As of Jul. 07, 2026)


FRA:04K Knight Therapeutics Inc FRA:04K
72 GF Score
Price €6.10
GF Value €5.27
! 6 Warning Signs
View Full Analysis

What is Knight Therapeutics Float Percentage Of Total Shares Outstanding?

Knight Therapeutics FRA:04K +0.83% 72 Float Percentage Of Total Shares Outstanding is 0.00% as of Jul. 07, 2026. GuruFocus rates FRA:04K with a GF Score™ of 72/100 and a GF Value™ of €5.27. The stock has 6 warning signs investors should review.

Float percentage of total shares outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Knight Therapeutics's float shares is 0.00 Mil. Knight Therapeutics's total shares outstanding is 98.18 Mil. Knight Therapeutics's float percentage of total shares outstanding is 0.00%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Knight Therapeutics's Insider Ownership is 0.00%.

Institutional Ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Knight Therapeutics's Institutional Ownership is 23.60%.

FRA:04K
72GF Score
Knight Therapeutics Inc FRA:04K
Float Percentage Of Total Shares Outstanding is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Knight Therapeutics Float Percentage Of Total Shares Outstanding Calculation

It is the percentage of float shares out of the total shares outstanding.

Knight Therapeutics's Float Percentage of Total Shares Outstanding for today is calculated as follows:

Float Percentage of Total Shares Outstanding=Float Shares/Total Shares Outstanding
=0.00/98.18
=0.00%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Float Percentage Of Total Shares Outstanding of 0.00% mean?
Knight Therapeutics (FRA:04K) has a Float Percentage Of Total Shares Outstanding of 0.00% as of Jul. 07, 2026. Float percent of shares outstanding equals the percent of float shares relative to total shares. View historical data on Knight Therapeutics and its competitors.
Is Knight Therapeutics' Float Percentage Of Total Shares Outstanding too high?
Knight Therapeutics' current Float Percentage Of Total Shares Outstanding is 0.00%. Overall, Knight Therapeutics has a GF Score™ of 72/100, reflecting its overall financial health beyond just this single metric.
How does Knight Therapeutics' Float Percentage Of Total Shares Outstanding compare to ZTS and UTHR?
Knight Therapeutics' Float Percentage Of Total Shares Outstanding of 0.00% can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Float Percentage Of Total Shares Outstanding for a Drug Manufacturers company?
A good Float Percentage Of Total Shares Outstanding depends on the Drug Manufacturers industry context. However, Float Percentage Of Total Shares Outstanding should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Float Percentage Of Total Shares Outstanding mean?
A high Float Percentage Of Total Shares Outstanding can signal that a stock is expensive relative to its fundamentals. Float percent of shares outstanding equals the percent of float shares relative to total shares. View historical data on Knight Therapeutics and its competitors. Knight Therapeutics's current Float Percentage Of Total Shares Outstanding is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Knight Therapeutics stock overvalued right now?
Knight Therapeutics (FRA:04K) has a current Float Percentage Of Total Shares Outstanding of 0.00%. The stock's GF Value™ is €5.27, compared to a current price of €6.10 — trading 15.7% above its estimated fair value. The current Float Percentage Of Total Shares Outstanding is 0.00%. Knight Therapeutics' overall GF Score™ is 72/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Float Percentage Of Total Shares Outstanding calculated?
Float Percentage Of Total Shares Outstanding is calculated from a company's financial statements. For Knight Therapeutics (FRA:04K), the current Float Percentage Of Total Shares Outstanding is 0.00% as of Jul. 07, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Knight Therapeutics (FRA:04K) Overvalued in 2026?

Based on GuruFocus' analysis, Knight Therapeutics stock appears to be overvalued. The current stock price of €6.10 is trading 15.7% above its estimated GF Value™ of €5.27.

Key valuation signals for FRA:04K:

  • Float Percentage Of Total Shares Outstanding: 0.00%
  • GF Value™: €5.27 vs. price of €6.10 (15.7% above fair value)
  • GF Score™: 72/100 with 6 warning signs

No single metric tells the full story. See the FRA:04K stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Knight Therapeutics Business Description

Other Exchanges KHTRF:USAGUD:Canada
Address 100 Alexis Nihon Boulevard, Suite 600, Saint-Laurent, QC, CAN, H4M 2P2
Knight Therapeutics Inc is a specialty and generic drug manufacturing company. The company's principal business activity is focused on developing, acquiring, in-licensing, out-licensing, marketing, and commercializing pharmaceuticalproducts. and distributing pharmaceutical products, consumer health products, and medical devices in Canada, Latin America and select international markets. The company finances other life sciences companies across the globe in order to generate interest income, strengthen relationships in the life sciences industry, and to secure product distribution rights. Geographically, the company generates revenue from Brazil, Canada, Colombia, Argentina, Mexico, Rest of LATAM, and Others, with the majority revenue generated from the Brazil region.
72GF Score

Get the complete analysis for FRA:04K

Float Percentage Of Total Shares Outstanding is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€6.10
Price
€5.27
GF Value